Trial
NCT05370040
THEMBA II T-Cell Vaccine: Vaccination With saRNA COVID-19 Vaccines
Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
ImmunityBio, Inc.
Collaborators
—
Condition
COVID-19
Intervention
AAHI-SC2 Vaccine
Why stopped
Discontinued prior to enroll in Phase 2
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-03-11